Get started
Author

Denis Sahin

Observed name: D. Sahin
ORCID: 0000-0003-1214-2447
Observed ORCID: 0000-0003-1214-2447
OpenAlex ID: A5041673752
Baseline PET-Derived Metabolic Tumor Volume Metrics Predict Progression-Free and Overall Survival in DLBCL after First-Line Treatment: Results from the Phase 3 GOYA Study
2017 · Lale Kostakoglu, Maurizio Martelli, et al. · Blood · 30
Englumafusp Alfa (CD19-4-1BBL) Combined with Glofitamab Is Safe and Efficacious in Patients with r/r B-NHL: Extended Follow up Analysis of the Dose-Escalation Part of Phase 1 Trial BP41072
2024 · Martin Hutchings, Michael J. Dickinson, et al. · Blood · 22
Automated Lugano Metabolic Response Assessment in 18 F-Fluorodeoxyglucose–Avid Non-Hodgkin Lymphoma With Deep Learning on 18 F-Fluorodeoxyglucose–Positron Emission Tomography
2024 · Skander Jemaa, Souhila Ounadjela, et al. · Journal of Clinical Oncology · 19
PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design
2022 · Kristine Broglio, Lale Kostakoglu, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 11
Follicular Lymphoma Treated with First-Line Immunochemotherapy: A Review of PET/CT in Patients Who Did Not Achieve a Complete Metabolic Response in the GALLIUM Study
2021 · Sally F. Barrington, Farheen Mir, et al. · Journal of Nuclear Medicine · 10
PDF
Role of obinutuzumab exposure on clinical outcome of follicular lymphoma treated with first‐line immunochemotherapy
2019 · Candice Jamois, Ekaterina Gibiansky, et al. · British Journal of Clinical Pharmacology · 8
PDF
The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study
2023 · Mette Abildgaard Pedersen, Lars C. Gormsen, et al. · British Journal of Haematology · 7
PDF
Calcium Channel Blockers Impair the Antitumor Activity of Anti-CD20 Monoclonal Antibodies by Blocking EGR-1 Induction
2020 · Ivana Spasevska, Eva Laure Matera, et al. · Molecular Cancer Therapeutics · 6
Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer
2018 · O. Ercelep, O. Alan, et al. · Clinical & Translational Oncology · 5
Prognostic Value of Pet‐ct After First‐line Immunochemotherapy for Follicular Lymphoma in the Phase Iii Gallium Study
2017 · J. Trotman, S. Barrington, et al. · Hematological Oncology · 5
PDF
PET Radiomics Discriminate Among Different Lymphoma Sub-Types
2024 · Stephane Chauvie, Lale Kostakoglu Shields, et al. · Blood · 2
PDF
Low Peripheral Blood NK Cell Count Is Associated with Worse Clinical Outcome in Patients with Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results from the Frontline Phase 3 GALLIUM and GOYA Trials
2017 · Magdalena Klanova, Mikkel Z. Oestergaard, et al. · Blood · 2
Integrated Quantitative Clinical Pharmacology Analysis Identifies Optimal Englumafusp Alfa Dose Range for Proof-of-Concept Study with Glofitamab in Second-Line Large B-Cell Lymphoma Patients
2024 · Candice Jamois, Koorosh Korfi, et al. · Blood · 1
PDF
P1191: Analysis of Peripheral Neuropathy Using Clinician- and Patient-reported Outcomes in the Polarix Study
2022 · M. Trněný, L. Fogliatto, et al. · HemaSphere · 1
Comparison Of Contrast-Enhanced Ct-Based Response With Pet Assessment After First-Line Therapy For Follicular Lymphoma In The Phase Iii Gallium Study
2017 · Judith Trotman, Sally F. Barrington, et al. · Haematologica · 1
Supplementary Data from Calcium Channel Blockers Impair the Antitumor Activity of Anti-CD20 Monoclonal Antibodies by Blocking EGR-1 Induction
2023 · Ivana Spasevska, Eva Laure Matera, et al.
Data from Calcium Channel Blockers Impair the Antitumor Activity of Anti-CD20 Monoclonal Antibodies by Blocking EGR-1 Induction
2023 · Ivana Spasevska, Eva Laure Matera, et al.
Data from Calcium Channel Blockers Impair the Antitumor Activity of Anti-CD20 Monoclonal Antibodies by Blocking EGR-1 Induction
2023 · Ivana Spasevska, Eva Laure Matera, et al.
Supplementary Data from Calcium Channel Blockers Impair the Antitumor Activity of Anti-CD20 Monoclonal Antibodies by Blocking EGR-1 Induction
2023 · Ivana Spasevska, Eva Laure Matera, et al.
PDF
The potential value and pitfalls of radiomics for clinical positron emission tomography (PET) in DLBCL: a comparison between two of most widely used segmentation thresholds
2021 · S. Chauvie, F. Dalmasso, et al. · Physica Medica
Influence of Baseline Disease Characteristics and Exposure to Obinutuzumab on Clinical Outcome in Patients with Previously Untreated Advanced Follicular Lymphoma Treated with Obinutuzumab-Based Immunochemotherapy in the GALLIUM Trial
2017 · Candice Jamois, Ekaterina Gibiansky, et al. · Blood
Works count: 21
Citation count: 130
H-index: 7
I10-index: 5
Year
Topic
Type